Esomeprazole Capsules (VA-27-00001026)   3

Background
The Department of Veterans Affairs (VA) is seeking to establish a contract for the supply of Esomeprazole Magnesium Capsules through its Pharmaceutical Prime Vendor (PPV) Program. The objective is to ensure availability and consistency of pharmaceutical products for nationwide usage, while obtaining volume-based, committed-use pricing. This contract will serve various government health care facilities including the VA, Department of Defense (DoD), Indian Health Service (IHS), and Bureau of Prisons (BOP).

Work Details
The contract includes the following line items for Esomeprazole Magnesium Capsules:

1. **Esomeprazole Magnesium 20mg Capsule**
- **Quantity**: 55,112 Bottles per year
- **Unit**: 30 Capsules per Bottle

2. **Esomeprazole Magnesium 20mg Capsule**
- **Quantity**: 21,059 Bottles per year
- **Unit**: 90 Capsules per Bottle

3. **Esomeprazole Magnesium 20mg Capsule**
- **Quantity**: 3,884 Bottles per year (500 Capsules per Bottle) or 1,942 Bottles per year (1,000 Capsules per Bottle)

4. **Esomeprazole 40 MG Capsule**
- **Quantity**: 299,341 Bottles per year
- **Unit**: 30 Capsules per Bottle

5. **Esomeprazole 40 MG Capsule**
- **Quantity**: 22,995 Bottles per year
- **Unit**: 90 Capsules per Bottle

6. **Esomeprazole 40 MG Capsule**
- **Quantity**: 11,208 Bottles per year (500 Capsules per Bottle) or 5,604 Bottles per year (1,000 Capsules per Bottle)

All unit-of-use packaging must contain safety caps and meet specific size requirements as outlined in the solicitation.

Period of Performance
The contract will be effective upon award and includes a base year with four one-year option periods.

Place of Performance
Products will be delivered to various VA and DoD facilities across the United States as designated by the PPV Program.

Bidder Requirements
Offerors must provide an NDC number unique to their company for each drug offered. If the offeror is a distributor, the NDC number must be unique to the distributor. Additionally, offerors must submit a Letter of Commitment from the manufacturer if they are not the manufacturer themselves. The offeror must maintain compliance with all applicable regulations and standards throughout the contract period.

Incumbent Analysis (see Incumbents section for more detail)
This opportunity for Esomeprazole capsules appears to have a confirmed incumbent and/or closely related prior contract history with Golden State Medical Supply, which received multiple delivery orders under VA repackaging programs for closely related proton pump inhibitor products (omeprazole 20 mg and 40 mg) during 2024–2025. Prior awards include Golden State Medical Supply delivery orders valued at $629,041 (05/27/25–07/31/25) and $567,470 (04/28/25–06/30/25), among others, covering similar repackaging/delivery activities and comparable capsule strengths. Because the prior work involves the same general drug class and repackaging program context, it appears to be a continuation of the supplier’s role supplying packaged oral PPI medications for VA use.